Loading...
•
Jun 30, 2023
AdaptHealth Q2 2023 Earnings Report
AdaptHealth's Q2 2023 results showed revenue growth and solid performance in core Sleep and Respiratory product lines, with significant cash generation and progress in cost-management.
Key Takeaways
AdaptHealth Corp. reported a 9.0% increase in net revenue to $793.3 million for Q2 2023, driven by strength in Sleep and Respiratory product lines. Net income attributable to AdaptHealth Corp. remained consistent at $14.0 million. The company is updating its financial guidance for fiscal year 2023.
Net revenue increased by 9.0% to $793.3 million.
Non-acquired net revenue growth was 8.7%.
Net income attributable to AdaptHealth Corp. was $14.0 million.
Adjusted EBITDA increased by 14.0% to $171.0 million.
Forward Guidance
The Company is updating previous financial guidance for fiscal year 2023 as follows: •Net revenue of $3.16 to $3.20 billion, from $3.16 to $3.24 billion •Adjusted EBITDA of $650 to $680 million, from $650 to $710 million •Total capital expenditures representing 10-12% of net revenue, unchanged •Free cash flow representing 3-4% of net revenue, unchanged
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...